Debra Durso-Bumpus - Jun 21, 2024 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Signature
/s/ Melissa Masse
Stock symbol
BPMC
Transactions as of
Jun 21, 2024
Transactions value $
-$5,628,036
Form type
4
Date filed
6/25/2024, 04:00 PM
Previous filing
Mar 11, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $247K +13.7K +23.97% $18.00 71.1K Jun 21, 2024 Direct F1
transaction BPMC Common Stock Options Exercise $127K +7.04K +9.91% $18.00 78.1K Jun 21, 2024 Direct F1
transaction BPMC Common Stock Options Exercise $872K +24.2K +30.99% $36.05 102K Jun 21, 2024 Direct F1
transaction BPMC Common Stock Options Exercise $839K +15.5K +15.15% $54.13 118K Jun 21, 2024 Direct F1
transaction BPMC Common Stock Sale -$166K -1.57K -1.33% $105.82 116K Jun 21, 2024 Direct F1, F2
transaction BPMC Common Stock Sale -$1.97M -18.8K -16.13% $104.98 97.5K Jun 21, 2024 Direct F1, F3
transaction BPMC Common Stock Sale -$4.2M -40.4K -41.4% $104.14 57.1K Jun 21, 2024 Direct F1, F4
transaction BPMC Common Stock Sale -$1.35M -13.1K -22.87% $103.05 44.1K Jun 21, 2024 Direct F1, F5
transaction BPMC Common Stock Sale -$30.7K -300 -0.68% $102.44 43.8K Jun 21, 2024 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -13.5K -100% $0.00* 0 Jun 21, 2024 Common Stock 13.5K $18.00 Direct F1, F7
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -7.04K -100% $0.00* 0 Jun 21, 2024 Common Stock 7.04K $18.00 Direct F1, F7
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -24.2K -100% $0.00* 0 Jun 21, 2024 Common Stock 24.2K $36.05 Direct F1, F8
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -15.5K -54.39% $0.00 13K Jun 21, 2024 Common Stock 15.5K $54.13 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on March 13, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.53 to $106.51 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (6) in this form 4.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $104.52 to $105.51 per share.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $103.53 to $104.51 per share.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $102.51 to $103.51 per share.
F6 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $102.44 to $102.45 per share.
F7 This option was granted on April 27, 2015 and is fully vested as of the transaction date.
F8 This option was granted on February 16, 2017 and is fully vested as of the transaction date.
F9 This option was granted on March 1, 2020 and is fully vested as of the transaction date.